The enteric toxins of Clostridium perfringens

被引:146
作者
Smedley, JG [1 ]
Fisher, DJ [1 ]
Sayeed, S [1 ]
Chakrabarti, G [1 ]
McClane, BA [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
来源
REVIEWS OF PHYSIOLOGY, BIOCHEMICAL AND PHARMACOLOGY, VOL 152 | 2005年 / 152卷
关键词
D O I
10.1007/s10254-004-0036-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Gram-positive pathogen Clostridium perfringens is a major cause of human and veterinary enteric disease largely because this bacterium can produce several toxins when present inside the gastrointestinal tract. The enteric toxins of C. perfringens share two common features: (1) they are all single polypeptides of modest (similar to 25-35 kDa) size, although lacking in sequence homology, and (2) they generally act by forming pores or channels in plasma membranes of host cells. These enteric toxins include C. perfringens enterotoxin (CPE), which is responsible for the symptoms of a common human food poisoning and acts by forming pores after interacting with intestinal tight junction proteins. Two other C. perfringens enteric toxins, epsilon-toxin (a bioterrorism select agent) and beta-toxin, cause veterinary enterotoxermas when absorbed from the intestines; beta- and epsilon-toxins then apparently act by forming oligomeric pores in intestinal or extra-intestinal target tissues. The action of a newly discovered C. perfringens enteric toxin, beta 2 toxin, has not yet been defined but precedent suggests it might also be a pore-former. Experience with other clostridial toxins certainly warrants continued research on these C. perfringens enteric toxins to develop their potential as therapeutic agents and tools for cellular biology.
引用
收藏
页码:183 / 204
页数:22
相关论文
共 101 条
[1]   Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000 [J].
Adak, GK ;
Long, SM ;
O'Brien, SJ .
GUT, 2002, 51 (06) :832-841
[2]   Tight junctions: Closing in on the seal [J].
Anderson, JM ;
Van Itallie, CM .
CURRENT BIOLOGY, 1999, 9 (24) :R922-R924
[3]  
Olsen S J, 2000, MMWR CDC Surveill Summ, V49, P1
[4]   Immunohistochemical localization of Clostridium perfringens β2-toxin in the gastrointestinal tract of horses [J].
Bacciarini, LN ;
Boerlin, P ;
Straub, R ;
Frey, J ;
Gröne, A .
VETERINARY PATHOLOGY, 2003, 40 (04) :376-381
[5]   Clostridium perfringens β2-toxin in an African elephant (Loxodonta africana) with ulcerative enteritis [J].
Bacciarini, LN ;
Pagan, O ;
Frey, J ;
Gröne, A .
VETERINARY RECORD, 2001, 149 (20) :618-620
[6]   DEVELOPMENT AND APPLICATION OF AN ENZYME LINKED IMMUNOSORBENT-ASSAY FOR CLOSTRIDIUM-PERFRINGENS TYPE-A ENTERO-TOXIN [J].
BARTHOLOMEW, BA ;
STRINGER, MF ;
WATSON, GN ;
GILBERT, RJ .
JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (02) :222-228
[7]   The development of tolerance to Clostridium perfringens type D ε-toxin in MDCK and G-402 cells [J].
Beal, DR ;
Titball, RW ;
Lindsay, CD .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2003, 22 (11) :593-605
[8]   Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis [J].
Boehning, D ;
Patterson, RL ;
Sedaghat, L ;
Glebova, NO ;
Kurosaki, T ;
Snyder, SH .
NATURE CELL BIOLOGY, 2003, 5 (12) :1051-1061
[9]   Salmonella-induced cell death:: apoptosis, necrosis or programmed cell death? [J].
Boise, LH ;
Collins, CM .
TRENDS IN MICROBIOLOGY, 2001, 9 (02) :64-67
[10]  
BORRIELLO SP, 1984, LANCET, V1, P305